Search by Drug Name or NDC

    NDC 68040-0714-28 Sernivo 0.5 mg/g Details

    Sernivo 0.5 mg/g

    Sernivo is a TOPICAL SPRAY in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Primus Pharmaceuticals, Inc.. The primary component is BETAMETHASONE DIPROPIONATE.

    Product Information

    NDC 68040-0714
    Product ID 68040-714_0ad18443-4f91-4789-a549-e6ca1cd4aae7
    Associated GPIs 90550020001620
    GCN Sequence Number 075550
    GCN Sequence Number Description betamethasone dipropionate SPRAY/PUMP 0.05 % TOPICAL
    HIC3 Q5P
    HIC3 Description TOPICAL ANTI-INFLAMMATORY STEROIDAL
    GCN 40655
    HICL Sequence Number 003304
    HICL Sequence Number Description BETAMETHASONE DIPROPIONATE
    Brand/Generic Brand
    Proprietary Name Sernivo
    Proprietary Name Suffix n/a
    Non-Proprietary Name betamethasone dipropionate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SPRAY
    Route TOPICAL
    Active Ingredient Strength 0.5
    Active Ingredient Units mg/g
    Substance Name BETAMETHASONE DIPROPIONATE
    Labeler Name Primus Pharmaceuticals, Inc.
    Pharmaceutical Class Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA208079
    Listing Certified Through 2024-12-31

    Package

    NDC 68040-0714-28 (68040071428)

    NDC Package Code 68040-714-28
    Billing NDC 68040071428
    Package 1 BOTTLE, SPRAY in 1 CARTON (68040-714-28) / 120 g in 1 BOTTLE, SPRAY
    Marketing Start Date 2021-06-28
    NDC Exclude Flag N
    Pricing Information N/A